Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
36.2M
-
Shares change
-
+3.06M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$82.5M
-
Put/Call ratio
-
5.36
-
Number of buys
-
132
-
Number of sells
-
-88
-
Price
-
$28.12
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2016
254 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q2 2016.
Emergent BioSolutions Inc. - Common Stock (EBS) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.2M shares
of 54.5M outstanding shares and own 66.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.61M shares), DIMENSIONAL FUND ADVISORS LP (2.15M shares), BlackRock Fund Advisors (2.01M shares), ACADIAN ASSET MANAGEMENT LLC (1.59M shares), RENAISSANCE TECHNOLOGIES LLC (1.27M shares), STATE STREET CORP (1.08M shares), GLENMEDE TRUST CO NA (955K shares), BlackRock Institutional Trust Company, N.A. (867K shares), D. E. Shaw & Co., Inc. (843K shares), and GOLDMAN SACHS GROUP INC (791K shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.